Key Metrics
1.85
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
16
H index
H-Index
Journal's h-index reflects the collective citation impact of the authors publishing in the journal. The h-index is defined as the maximum value of h such that the given journal has published at least h papers that have each been cited at least h times.
0.6
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
Indexed in the following public directories
-
CrossRef -
Scopus -
Web of Science
Topics Covered
- Hunter syndrome
- Clinical trial
- Adeno-associated virus
- Osteoarthritis
- Neuroscience
Journal Specifications
| Overview | |
| Publisher | MARY ANN LIEBERT, INC |
| Language | English |
| Frequency | Quarterly |
| General Details | |
| Language | English |
| Frequency | Quarterly |
| Publication Start Year | 2013 |
| Publisher URL | Visit website |
Planning to publish in Human Gene Therapy Clinical Development ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Gene Therapy Briefs
- 1 Sep 19
- Human Gene Therapy Clinical Development
-
Full paper
Ultrasound-Targeted Microbubble Destruction Delivery of <i>Insulin-Like Growth Factor 1</i> cDNA and <i>Transforming Growth Factor Beta</i> Short Hairpin RNA Enhances Tendon Regeneration and Inhibits Scar Formation <i>In Vivo</i>
- 25 Oct 18
- Human Gene Therapy Clinical Development
-
Full paper
A phase I trial of oncolytic adenovirus ICOVIR-5 administered intravenously to melanoma patients
- 18 Sep 18
- Human Gene Therapy Clinical Development
-
Full paper
Long-Term Follow-Up of a Phase I/II Study of ProSavin, a Lentiviral Vector Gene Therapy for Parkinson's Disease
- 1 Sep 18
- Human Gene Therapy Clinical Development
-
Full paper
Correction to: <i>Low Seroprevalence of Neutralizing Antibodies Targeting Two Clade F AAV in Humans,</i> by Ellsworth JL, O'Callaghan M, Rubin H, and Seymour A.
- 1 Jun 18
- Human Gene Therapy Clinical Development
-
Full paper
Low Seroprevalence of Neutralizing Antibodies Targeting Two Clade F AAV in Humans
- 27 Feb 18
- Human Gene Therapy Clinical Development
Scite analysis
Powered by scite_
238 articles received 3k citations see all
- 79 Supporting
- 2,856 Mentioning
- 9 Contrasting
Editorial notices
- 0 Retractions
- 0 Withdrawals
- 0 Corrections
- 4 Errata
- 0 Expression of Concern
FAQs
How long has Human Gene Therapy Clinical Development been actively publishing?
Human Gene Therapy Clinical Development has been in operation since 2013 till date.
What is the publishing frequency of Human Gene Therapy Clinical Development ?
Human Gene Therapy Clinical Development published with a Quarterly frequency.
How many articles did Human Gene Therapy Clinical Development publish last years ?
In 2023, Human Gene Therapy Clinical Development published articles.
What is the eISSN & pISSN for Human Gene Therapy Clinical Development ?
For Human Gene Therapy Clinical Development,eISSN is 2324-8645 and pISSN is2324-8637.
What is Citescore for Human Gene Therapy Clinical Development ?
Citescore for Human Gene Therapy Clinical Development is 1.85.
What is H index for Human Gene Therapy Clinical Development ?
H index for Human Gene Therapy Clinical Development is 16.
What is SNIP score for Human Gene Therapy Clinical Development ?
SNIP score for Human Gene Therapy Clinical Development is 0.6.
Who is the publisher of Human Gene Therapy Clinical Development ?
MARY ANN LIEBERT, INC is the publisher of Human Gene Therapy Clinical Development.